R&D
Why UCB bet a billion dollars on cell therapy for epilepsy
UCB's chief science officer spoke to pharmaphorum about why Neurona's in-development cell therapy could be a game changer for epilepsy treatment.
R&D
Bridging ethics and efficacy in IRB review of vaccine trials
Institutional Review Boards (IRBs) play a key role in evaluating scientific integrity and participant safety.
R&D
A patient-first mindset for change
May marks World Clinical Trials Day, bringing awareness to trials and the vital role they play.
Digital
Closing the gap between diagnosis and treatment adherence wi...
For organisations, digital tools are increasingly critical to understanding and influencing patient behaviour between diagnosis and treatment.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
